10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38MAPK activity

Joo,Ji-Hye; Hong,Seong-Su; Cho,Young-Rak; Seo,Dong-Wan

doi:10.3892/or.2015.4405

10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38MAPK activity

Authors:
- Ji-Hye Joo
- Seong-Su Hong
- Young-Rak Cho
- Dong-Wan Seo
View Affiliations

Affiliations: Department of Pharmacy, College of Pharmacy, Dankook University, Cheonan 31116, Republic of Korea, Gyeonggi Biocenter, Gyeonggi Institute of Science and Technology Promotion, Suwon 16229, Republic of Korea
Published online on: November 9, 2015 https://doi.org/10.3892/or.2015.4405
Pages: 779-784

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, we investigated the roles and molecular mechanism of 10-gingerol, a phenolic compound isolated from Zingiber officinale, in regulating cell proliferation and invasion of MDA‑MB‑231 breast cancer cells. 10-gingerol treatment inhibited cell proliferation through downregulation of cell cycle regulatory proteins such as cyclin-dependent kinases and cyclins, and subsequent induction of G1 phase arrest. In addition, 10‑gingerol treatment blocked cell invasion in response to mitogenic stimulation. These antitumor activities of 10‑gingerol were mediated through inactivation of Akt and p38MAPK activity, and suppression of epidermal growth factor receptor expression. Collectively, these findings demonstrate the pharmacological roles of 10-gingerol in regulating breast cancer cell growth and progression, and suggest further evaluation and development as a potential therapeutic agent for the prevention and treatment of breast cancer.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Guo M, Wang M, Deng H, Zhang X and Wang Z-Y: A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells. Eur J Pharmacol. 714:56–64. 2013. View Article : Google Scholar : PubMed/NCBI
3	Munoz J, Wheler J and Kurzrock R: Expression of estrogen and progesterone receptors across human malignancies: New therapeutic opportunities. Cancer Metastasis Rev. Dec 28–2014.Epub ahead of print. PubMed/NCBI
4	Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat. 136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
5	Dawood S, Broglio K, Buzdar AU, Hortobagyi GN and Giordano SH: Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review. J Clin Oncol. 28:92–98. 2010. View Article : Google Scholar :
6	Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010. View Article : Google Scholar : PubMed/NCBI
7	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
8	Stetler-Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci Signal. 1:re62008. View Article : Google Scholar : PubMed/NCBI
9	Vandenbroucke RE and Libert C: Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 13:904–927. 2014. View Article : Google Scholar : PubMed/NCBI
10	Hadler-Olsen E, Winberg J-O and Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
11	Oyagbemi AA, Saba AB and Azeez OI: Molecular targets of [6]-gingerol: Its potential roles in cancer chemoprevention. Biofactors. 36:169–178. 2010. View Article : Google Scholar : PubMed/NCBI
12	Shukla Y and Singh M: Cancer preventive properties of ginger: A brief review. Food Chem Toxicol. 45:683–690. 2007. View Article : Google Scholar
13	Baliga MS, Haniadka R, Pereira MM, D'Souza JJ, Pallaty PL, Bhat HP and Popuri S: Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr. 51:499–523. 2011. View Article : Google Scholar : PubMed/NCBI
14	Lee T-Y, Lee K-C, Chen S-Y and Chang H-H: 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-α and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem Biophys Res Commun. 382:134–139. 2009. View Article : Google Scholar : PubMed/NCBI
15	Lee HS, Seo EY, Kang NE and Kim WK: [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem. 19:313–319. 2008. View Article : Google Scholar
16	Lee S-H, Cekanova M and Baek SJ: Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog. 47:197–208. 2008. View Article : Google Scholar :
17	Brown AC, Shah C, Liu J, Pham JTH, Zhang JG and Jadus MR: Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother Res. 23:640–645. 2009. View Article : Google Scholar : PubMed/NCBI
18	Weng C-J, Wu C-F, Huang H-W, Ho C-T and Yen G-C: Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol Nutr Food Res. 54:1618–1627. 2010. View Article : Google Scholar : PubMed/NCBI
19	Kim MO, Lee M-H, Oi N, Kim SH, Bae KB, Huang Z, Kim DJ, Reddy K, Lee SY, Park SJ, et al: [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis. 35:683–691. 2014. View Article : Google Scholar :
20	Fan J, Yang X and Bi Z: 6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation. Tumour Biol. 36:1135–1141. 2015. View Article : Google Scholar
21	Kim JS, Lee SI, Park HW, Yang JH, Shin TY, Kim YC, Baek NI, Kim SH, Choi SU, Kwon BM, et al: Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch Pharm Res. 31:415–418. 2008. View Article : Google Scholar : PubMed/NCBI
22	Sang S, Hong J, Wu H, Liu J, Yang CS, Pan MH, Badmaev V and Ho CT: Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols. J Agric Food Chem. 57:10645–10650. 2009. View Article : Google Scholar : PubMed/NCBI
23	Cho Y-R, Choi SW and Seo D-W: The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways. Oncol Rep. 30:221–226. 2013.PubMed/NCBI
24	Kim H-J, Ko H-Y, Choi S-W and Seo D-W: Anti-angiogenic effects of Siegesbeckia glabrescens are mediated by suppression of the Akt and p70S6K-dependent signaling pathways. Oncol Rep. 33:699–704. 2015.
25	Lee HN, Kim J-K, Kim JH, Lee SJ, Ahn EK, Oh JS and Seo DW: A mechanistic study on the anti-cancer activity of ethyl caffeate in human ovarian cancer SKOV-3 cells. Chem Biol Interact. 219:151–158. 2014. View Article : Google Scholar : PubMed/NCBI
26	Kim SH, Cho Y-R, Kim H-J, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, et al: Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway. Blood. 120:4892–4902. 2012. View Article : Google Scholar : PubMed/NCBI
27	Kim H-J, Cho Y-R, Kim SH and Seo D-W: TIMP-2-derived 18-mer peptide inhibits endothelial cell proliferation and migration through cAMP/PKA-dependent mechanism. Cancer Lett. 343:210–216. 2014. View Article : Google Scholar
28	Lee HN, Joo J-H, Oh JS, Choi SW and Seo D-W: Regulatory effects of Siegesbeckia glabrescens on non-small cell lung cancer cell proliferation and invasion. Am J Chin Med. 42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
29	Yoon HJ, Cho Y-R, Joo J-H and Seo D-W: Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells. Oncol Rep. 29:662–668. 2013.
30	Cho Y-R, Kim JH, Kim J-K, Ahn EK, Ko HJ, In JK, Lee SJ, Bae U, Kim YK, Oh JS, et al: Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6K dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation. Oncol Rep. 32:1531–1536. 2014.PubMed/NCBI
31	Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M and Sinha N: Therapeutic targets of triple-negative breast cancer: A review. Br J Pharmacol. 172:4228–4237. 2015. View Article : Google Scholar : PubMed/NCBI
32	Ali BH, Blunden G, Tanira MO and Nemmar A: Some phyto-chemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol. 46:409–420. 2008. View Article : Google Scholar
33	Weng C-J, Chou C-P, Ho C-T and Yen G-C: Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol. Mol Nutr Food Res. 56:1304–1314. 2012. View Article : Google Scholar : PubMed/NCBI
34	Seo D-W, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY and Stetler-Stevenson WG: TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell. 114:171–180. 2003. View Article : Google Scholar : PubMed/NCBI
35	Burness ML, Grushko TA and Olopade OI: Epidermal growth factor receptor in triple-negative and basal-like breast cancer: Promising clinical target or only a marker? Cancer J. 16:23–32. 2010. View Article : Google Scholar : PubMed/NCBI